FY19
20
|
FY18
37
|
FY17
27
|
FY16
23
|
FY19
-0.377
|
FY18
-0.687
|
FY17
-0.221
|
FY16
-0.172
|
Misonix, Inc. designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company's products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties. The BoneScalpel is an ultrasonic cutting system that makes cuts with minimal necrosis, minimal burn artifact, minimal inflammation and minimal bone loss. The SonaStar system provides precise aspiration following the ultrasonic ablation of hard or soft tissue. The SonicOne Ultrasonic Cleansing and Debridement System is a tissue specific approach for the removal of devitalized or necrotic tissue and fibrin deposits while sparing viable, surrounding cellular structures.